GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - August 24, 1999JAMC - le 24 août 1999

Tuberculosis: 9. Treatment

Table 1: Doses of and common adverse reactions to first-line antituberculosis drugs*

    Usual dose, mg  
   
 
Drug  Daily dose for 
 adults and 
 children, mg/kg 
If given
daily
 If given twice 
weekly
Common adverse reactions†

Isoniazid 5-10 300  900–1200  Hepatitis, peripheral neuropathy
Rifampin‡ 10    600 600 Hepatitis, flu-like illness (reduced effect of some other drugs)
Pyrazinamide 15–30 1500 2500 Hepatitis, elevated serum level of uric acid, arthralgia
Ethambutol 15–25 800–1200 2400 Retrobulbar neuritis
Streptomycin 15-20 1000 1000 Vertigo, tinnitus, renal failure

Note: In alcoholic patients, diabetic patients and pregnant women, or if there is a concern for the patient's nutritional status, vitamin B6 (25-50 mg/day) may be prescribed.
*Adapted from the Tuberculosis Committee of the Canadian Thoracic Society,17 and the American Thoracic Society.18
†All drugs may cause rash, nausea and fever.
‡Rifabutin and rifapentine have similar properties.

[Return to text]